Lagerstroemia macrocarpa extract inhibits Th2-mediated STAT6 signaling pathway in human keratinocytes

Gayeon Seo,Hoyong Hyun,Minju Jeong,Yukyung Park,Jeongmin Cho,Thet Thet Mar Win,Thant Zaw Win,Jinhyup Paik,Alfan D Arbianto,Jung-Hee Kim,Jongmin Ahn,Dongwon Kim,Alfan D. Arbianto
DOI: https://doi.org/10.1016/j.fitote.2024.105859
IF: 3.204
2024-04-01
Fitoterapia
Abstract:In this study, we examined physiological functions as a key material to develop cosmeceuticals using extracts of Lagerstroemia macrocarpa Wall. Ex Kurz (L. macrocarpa). Initially, the L. macrocarpa extract was treated by different concentration and antioxidant assay (DPPH and ABTS) were performed to measure free radical scavenging ability. In the cytotoxicity experiment, the extract was treated into human epidermal keratinocytes with different concentrations to measure cytotoxicity. We found that the extract induces differentiation markers such as keratin (KRT)1, KRT2, KRT9, KRT10 in keratinocytes. Furthermore, the extract significantly induces involucrin (IVL), loricrin (LOR), claudin1 (CLDN1), and filaggrin (FLG) expression, suggesting that it may enhance skin barrier functions. Especially, the extract restored FLG expression inhibited by interleukin (IL)-4/IL-13 in in vitro atopic dermatitis-like model. Therefore, we expect L. macrocarpa extract will be an effective material to develop the therapeutic and cosmeceutical of atopic dermatitis.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?